A NEW HOPE FOR WEIGHT CONTROL ?

Experts are increasingly focused on retatrutide, a promising drug created by Eli Lilly, as a potential step in physique management. Different than many existing approaches, retatrutide is a dual -action agonist targeting equally GLP-1 and GIP, substances that impact appetite and glucose control